The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies
Value Health
.
2014 Nov;17(7):A347-8.
doi: 10.1016/j.jval.2014.08.712.
Epub 2014 Oct 26.
Authors
A Baptista
1
,
I Teixeira
1
,
S Romano
1
,
Carneiro A Vaz
2
,
J Perelman
3
Affiliations
1
Centre of Health Research & Evaluation (CEFAR), National Association of Pharmacies (ANF), Lisbon, Portugal.
2
Center for Evidence Based Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
3
Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.
PMID:
27200662
DOI:
10.1016/j.jval.2014.08.712
No abstract available